Dr Brendan Jacka

Jacka BP; Ziobrowski HN; Lawrence A; Baird J; Wentz AE; Marshall BDL; Wightman RS; Mello MJ; Beaudoin FL; Samuels EA, 2022, 'Implementation and maintenance of an emergency department naloxone distribution and peer recovery specialist program', Academic Emergency Medicine, vol. 29, pp. 294 - 307, http://dx.doi.org/10.1111/acem.14409

Min S; Shin J; Jacka B; Bazerman L; Nijhawan AE; Beckwith C, 2021, '841. Survey of Current HIV and HCV Policies and Practices in Prisons and Jails Serving High-Risk Geographic Hotspots', Open Forum Infectious Diseases, vol. 8, pp. S511 - S512, http://dx.doi.org/10.1093/ofid/ofab466.1037

Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA, 2021, 'Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation', American Journal of Emergency Medicine, vol. 50, pp. 409 - 412, http://dx.doi.org/10.1016/j.ajem.2021.08.071

Reddy NG; Jacka B; Ziobrowski HN; Wilson T; Lawrence A; Beaudoin FL; Samuels EA, 2021, 'Race, ethnicity, and emergency department post-overdose care', Journal of Substance Abuse Treatment, vol. 131, http://dx.doi.org/10.1016/j.jsat.2021.108588

Jacka B; Beaudoin F; Li Y; Nimaja E; Yedinak J; Samuels E; Marshall BDL, 2021, 'Objective Outcome Measures in Randomized Clinical Trials of Interventions to Reduce Risk of Opioid Overdose Following Discharge From the Emergency Department: Utility of Administrative Data Linkage', Journal of addiction medicine, vol. 15, pp. 174 - 175, http://dx.doi.org/10.1097/ADM.0000000000000705

Jacka BP; Janssen T; Garner BR; Yermash J; Yap KR; Ball EL; Hartzler B; Becker SJ, 2021, 'Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder', Drug and Alcohol Dependence, vol. 221, http://dx.doi.org/10.1016/j.drugalcdep.2021.108617

Singleton AL; Marshall BDL; Bessey S; Harrison MT; Galvani AP; Yedinak JL; Jacka BP; Goodreau SM; Goedel WC, 2021, 'Network structure and rapid HIV transmission among people who inject drugs: A simulation-based analysis', Epidemics, vol. 34, http://dx.doi.org/10.1016/j.epidem.2020.100426

Høj SB; Jacka B; Minoyan N; Bussière P; Bruneau J, 2021, 'Deconstructing the ‘cheque effect’: short-term changes in injection drug use after receiving income assistance and associated factors', Addiction, vol. 116, pp. 571 - 582, http://dx.doi.org/10.1111/add.15192

Cho D; Jacka B; Marshall B; Beaudoin F, 2021, '239 Evaluating the Role of Recovery Capital on Willingness to Enter Treatment for Emergency Department Patients With Opioid Use Disorders', Annals of Emergency Medicine, vol. 78, pp. S97 - S97, http://dx.doi.org/10.1016/j.annemergmed.2021.09.251

Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL, 2020, 'A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial', Trials, vol. 21, http://dx.doi.org/10.1186/s13063-020-04898-8

Gaur DS; Jacka BP; Green TC; Samuels EA; Hadland SE; Krieger MS; Yedinak JL; Marshall BDL, 2020, 'US drug overdose mortality: 2009–2018 increases affect young people who use drugs', International Journal of Drug Policy, vol. 85, http://dx.doi.org/10.1016/j.drugpo.2020.102906

Jacka BP; Phipps E; Marshall BDL, 2020, 'Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs', International Journal of Drug Policy, vol. 83, http://dx.doi.org/10.1016/j.drugpo.2020.102895

Picard J; Jacka B; Høj S; Laverdière É; Cox J; Roy É; Bruneau J, 2020, 'Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs', AIDS and Behavior, vol. 24, pp. 2400 - 2408, http://dx.doi.org/10.1007/s10461-020-02800-w

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, vol. 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Jacka B; Larney S; Degenhardt L; Janjua N; Høj S; Krajden M; Grebely J; Bruneau J, 2020, 'Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada', American Journal of Public Health, vol. 110, pp. 45 - 50, http://dx.doi.org/10.2105/AJPH.2019.305379

Catlett B; Lamoury FMJ; Bajis S; Hajarizadeh B; Martinez D; Mowat Y; Cunningham PH; Jacka BP; Cloherty GA; Marks P; Dore GJ; Grebely J; Applegate TL, 2019, 'Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study', Journal of Viral Hepatitis, vol. 26, pp. 1423 - 1430, http://dx.doi.org/10.1111/jvh.13196

Jacka B; Roy É; Høj S; Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Bruneau J, 2019, 'Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada', Journal of Viral Hepatitis, vol. 26, pp. 1413 - 1422, http://dx.doi.org/10.1111/jvh.13194

Makarenko I; Artenie A; Hoj S; Minoyan N; Jacka B; Zang G; Barlett G; Jutras-Aswad D; Martel-Laferriere V; Bruneau J, 2019, 'Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?', International Journal of Drug Policy, vol. 72, pp. 69 - 76, http://dx.doi.org/10.1016/j.drugpo.2019.04.002

Høj SB; Jacka B; Minoyan N; Artenie AA; Bruneau J, 2019, 'Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs', International Journal of Drug Policy, vol. 72, pp. 11 - 23, http://dx.doi.org/10.1016/j.drugpo.2019.04.001

Artenie AA; Minoyan N; Jacka B; Høj S; Jutras-Aswad D; Roy É; Gauvin L; Zang G; Bruneau J, 2019, 'Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs', CMAJ, vol. 191, pp. E462 - E468, http://dx.doi.org/10.1503/cmaj.181506

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, vol. 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222

Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B, 2019, 'Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007–2015', Drug and Alcohol Review, vol. 38, pp. 159 - 168, http://dx.doi.org/10.1111/dar.12908

Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B, 2018, 'Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic–androgenic steroid users', Drug and Alcohol Review, vol. 37, pp. 664 - 670, http://dx.doi.org/10.1111/dar.12688

Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J, 2018, 'Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach', Journal of Viral Hepatitis, vol. 25, pp. 28 - 36, http://dx.doi.org/10.1111/jvh.12758

Jacka B; Peacock A; Degenhardt L; Bruno R; Clare P; Kemp R; Dev A; Larance B, 2017, 'Trends in PIEDs use among male clients of needle–syringe programs in Queensland, Australia; 2007–2015', International Journal of Drug Policy, vol. 46, pp. 74 - 78, http://dx.doi.org/10.1016/j.drugpo.2017.05.048

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, vol. 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050

Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, vol. 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0

Montoya V; Olmstead A; Tang P; Cook D; Janjua N; Grebely J; Jacka B; Poon AFY; Krajden M, 2016, 'Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing', Infection, Genetics and Evolution, vol. 43, pp. 329 - 337, http://dx.doi.org/10.1016/j.meegid.2016.06.015

Bradshaw D; Raghwani J; Jacka B; Sacks-Davis R; Lamoury F; Down I; Prestage G; Applegate TL; Hellard M; Sasadeusz J; Dore GJ; Pybus OG; Matthews GV; Danta M, 2016, 'Venue-based networks may underpin HCV transmissions amongst HIV-infected gay and bisexual men', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0162002

Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; Debeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BDL; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J, 2016, 'Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada', Journal of Hepatology, vol. 64, pp. 1247 - 1255, http://dx.doi.org/10.1016/j.jhep.2016.02.031

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437

Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BDL; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J, 2015, 'Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada', Drug and Alcohol Dependence, vol. 152, pp. 272 - 276, http://dx.doi.org/10.1016/j.drugalcdep.2015.04.005

Olmstead AD; Joy JB; Montoya V; Luo I; Poon AFY; Jacka B; Lamoury F; Applegate T; Montaner J; Khudyakov Y; Grebely J; Cook D; Harrigan PR; Krajden M, 2015, 'A molecular phylogenetics-based approach for identifying recent hepatitis C virus transmission events', Infection, Genetics and Evolution, vol. 33, pp. 101 - 109, http://dx.doi.org/10.1016/j.meegid.2015.04.017

Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003

Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall BDL; Debeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AFY; Grebely J, 2014, 'Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada', Hepatology, vol. 60, pp. 1571 - 1580, http://dx.doi.org/10.1002/hep.27310

Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'Sequencing of the Hepatitis C Virus: A Systematic Review', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0067073

Baleriola-Lucas C; Johal H; Jacka B; Whybin R; Taylor PCA; Rawlinson WD; robertson P, 2012, 'Infectious disease screening of blood specimens collected post-mortem provides comparable results to pre-mortem specimens', Cell and Tissue Banking, vol. 13, pp. 251 - 258, http://dx.doi.org/10.1007/s10561-011-9252-6

Baleriola C; Johal H; Jacka B; Chaverot S; Bowden S; Lacey S; Rawlinson WD, 2011, 'Stability of HCV, HIV and HBV nucleic acid in plasma samples after long-term storage at -20°C and -70°C', Journal of Clinical Microbiology, vol. 49, pp. 3163 - 3167, http://dx.doi.org/10.1128/JCM.02447-10

Dolan K; Larney S; Jacka B; Rawlinson WD, 2009, 'Presence of hepatitis C virus in syringes confiscated in prisons in Australia', Journal of Gastroenterology and Hepatology, vol. 24, pp. 1655 - 1657, http://dx.doi.org/10.1111/j.1440-1746.2009.05978.x

Jacka B; Applegate T; Poon AF; Harrigan R; Dore GJ; Olmstead A; DeBeck K; Milloy M-J; Lamoury F; Woods C; Brumme Z; Dobrer S; Lima VD; Montaner J; Joy J; Marshall BD; Kerr T; Wood E; Krajden M; Grebely J, 2014, 'TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, ENGLAND, London, pp. S324 - S325, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/S0168-8278(14)60923-5

Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate T; Dore G; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2014, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive MSM with acute HCV infection identifies two potential intervention targets for permucosally transmitted HCV in Australia', in HIV MEDICINE, WILEY-BLACKWELL, pp. 136 - 136, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000333652300418&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate TL; Dore GJ; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2013, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive men who have sex with men (MSM) with acute HCV infection identifies two potential intervention targets for permucosally-transmitted HCV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 1307A - 1307A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330252206224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, 'SEQUENCING THE HEPATITIS C VIRUS: A SYSTEMATIC REVIEW', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S471 - S472, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), NETHERLANDS, Amsterdam, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)61160-5